文献速递流行病学与生物统计

妊娠期糖尿病与不良妊娠结局:系统综述与荟萃分析

Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis.
PubMed 文献 · BMJ · 2022-05-25

该系统综述与荟萃分析纳入156项研究、共7506061例妊娠,评估校正混杂因素后妊娠期糖尿病与不良妊娠结局的关联。在不使用胰岛素的亚组中,妊娠期糖尿病与剖宫产、早产、低1分钟Apgar评分、巨大儿和大于胎龄儿风险升高相关;使用胰岛素的亚组中,大于胎龄儿、呼吸窘迫综合征、新生儿黄疸和新生儿重症监护入住风险升高。

要点

  • 不使用胰岛素亚组:妊娠期糖尿病与剖宫产、早产、低1分钟Apgar评分、巨大儿、大于胎龄儿风险升高相关。
  • 使用胰岛素亚组:大于胎龄儿、呼吸窘迫综合征、新生儿黄疸及新生儿重症监护入住风险升高。
  • 器械助产、肩难产、产后出血、死产、新生儿死亡等结局未发现明确差异证据。

核心结论

  • 校正混杂因素后,妊娠期糖尿病与妊娠并发症显著相关。

研究设计与样本

  • 系统综述与荟萃分析,检索Web of Science、PubMed、Medline和Cochrane系统综述数据库,时间自1990年1月1日至2021年11月1日。
  • 纳入报告妊娠期糖尿病女性妊娠并发症的队列研究和试验对照组,共156项研究、7506061例妊娠。
  • 50项研究(32.1%)显示低或中等偏倚风险。

主要发现

  • 不使用胰岛素亚组中,校正混杂因素后妊娠期糖尿病女性剖宫产(比值比1.16,95%置信区间1.03至1.32)、早产(1.51,1.26至1.80)、低1分钟Apgar评分(1.43,1.01至2.03)、巨大儿(1.70,1.23至2.36)和大于胎龄儿(1.57,1.25至1.97)的比值比升高。
  • 使用胰岛素亚组中,校正混杂因素后妊娠期糖尿病女性大于胎龄儿(比值比1.61,95%置信区间1.09至2.37)、呼吸窘迫综合征(1.57,1.19至2.08)、新生儿黄疸(1.28,1.02至1.62)和新生儿重症监护入住(2.29,1.59至3.31)的比值比高于无糖尿病女性。
  • 校正混杂因素后,器械助产、肩难产、产后出血、死产、新生儿死亡、低5分钟Apgar评分、低出生体重和小于胎龄儿的比值比在妊娠期糖尿病与无糖尿病女性之间未发现明确差异证据。
  • 国家状态、体质指数校正和筛查方法对多项不良妊娠结局的研究间异质性有显著贡献。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 仅50项研究(32.1%)显示低或中等偏倚风险。
  • 国家状态、体质指数校正和筛查方法对多项不良妊娠结局的研究间异质性有显著贡献。
  • 未来原始研究应常规考虑校正更完整的预后因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the association between gestational diabetes mellitus and adverse outcomes of pregnancy after adjustment for at least minimal confounding factors. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Web of Science, PubMed, Medline, and Cochrane Database of Systematic Reviews, from 1 January 1990 to 1 November 2021. REVIEW METHODS: Cohort studies and control arms of trials reporting complications of pregnancy in women with gestational diabetes mellitus were eligible for inclusion. Based on the use of insulin, studies were divided into three subgroups: no insulin use (patients never used insulin during the course of the disease), insulin use (different proportions of patients were treated with insulin), and insulin use not reported. Subgroup analyses were performed based on the status of the country (developed or developing), quality of the study, diagnostic criteria, and screening method. Meta-regression models were applied based on the proportion of patients who had received insulin. RESULTS: 156 studies with 7 506 061 pregnancies were included, and 50 (32.1%) showed a low or medium risk of bias. In studies with no insulin use, when adjusted for confounders, women with gestational diabetes mellitus had increased odds of caesarean section (odds ratio 1.16, 95% confidence interval 1.03 to 1.32), preterm delivery (1.51, 1.26 to 1.80), low one minute Apgar score (1.43, 1.01 to 2.03), macrosomia (1.70, 1.23 to 2.36), and infant born large for gestational age (1.57, 1.25 to 1.97). In studies with insulin use, when adjusted for confounders, the odds of having an infant large for gestational age (odds ratio 1.61, 1.09 to 2.37), or with respiratory distress syndrome (1.57, 1.19 to 2.08) or neonatal jaundice (1.28, 1.02 to 1.62), or requiring admission to the neonatal intensive care unit (2.29, 1.59 to 3.31), were higher in women with gestational diabetes mellitus than in those without diabetes. No clear evidence was found for differences in the odds of instrumental delivery, shoulder dystocia, postpartum haemorrhage, stillbirth, neonatal death, low five minute Apgar score, low birth weight, and small for gestational age between women with and without gestational diabetes mellitus after adjusting for confounders. Country status, adjustment for body mass index, and screening methods significantly contributed to heterogeneity between studies for several adverse outcomes of pregnancy. CONCLUSIONS: When adjusted for confounders, gestational diabetes mellitus was significantly associated with pregnancy complications. The findings contribute to a more comprehensive understanding of the adverse outcomes of pregnancy related to gestational diabetes mellitus. Future primary studies should routinely consider adjusting for a more complete set of prognostic factors. REVIEW REGISTRATION: PROSPERO CRD42021265837.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Ye W, Luo C, Huang J, et al. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022. PMID: 35613728. doi:10.1136/bmj-2021-067946

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。